Set of monocyte I chemically attractive protein inhibitors used for treating e.g. arteriosclerosis comprises natural tricyclic products of fermentation
Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protei...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VALMASEDA JADU MANUEL ELSON STEVE W DIEZ MONEDERO EMILIO SANCHEZ-PUELLES JOSE MARIA DE LA FUENTE CARRALERO JESUS HUESO RODRIGUEZ JUAN ANTONIO |
| description | Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors.
Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors. (Machine-translation by Google Translate, not legally binding)
Productos naturales tricíclicos como inhibidores de la proteína quimioatrayente de monocitos 1. La invención describe un compuesto nuevo de la fórmula (I) y su empleo como un inhibidor de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. También se describe el empleo de los compuestos conocidos en la bibliografía científica como la gunacina y la gunacina saponificada como inhibidores de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. Los compuestos son producidos por la fermentación del hongo Scytalidium flavo-brumeum. Los compuestos son útiles en el tratamiento de ateroesclerosis y otras enfermedades en las cuales se implican la superestimulación de infiltración por monocitos y daño al tejido por macrófagos. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2162545A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2162545A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2162545A13</originalsourceid><addsrcrecordid>eNqNjjtuAlEMRaehiIA9eAMg8UuPECipSY-MuQOW3jyPbE-kWUm2G5CygFS3OefovjU_ZyRZS51VkzFBnyQPdCpcykic6Syp36DeLaGVtD70qmkeNARu1JpTOji13gnL-5LYE64WUuAWGiTW9a6BoMo5OJenoDJKUXllb4NkvD608A41nymrs2bScgnM_3ba0On4dfhYoLcLomdBRV6O5_Xqfb3b7varzT-QX_rJUtY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Set of monocyte I chemically attractive protein inhibitors used for treating e.g. arteriosclerosis comprises natural tricyclic products of fermentation</title><source>esp@cenet</source><creator>VALMASEDA JADU MANUEL ; ELSON STEVE W ; DIEZ MONEDERO EMILIO ; SANCHEZ-PUELLES JOSE MARIA ; DE LA FUENTE CARRALERO JESUS ; HUESO RODRIGUEZ JUAN ANTONIO</creator><creatorcontrib>VALMASEDA JADU MANUEL ; ELSON STEVE W ; DIEZ MONEDERO EMILIO ; SANCHEZ-PUELLES JOSE MARIA ; DE LA FUENTE CARRALERO JESUS ; HUESO RODRIGUEZ JUAN ANTONIO</creatorcontrib><description>Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors.
Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors. (Machine-translation by Google Translate, not legally binding)
Productos naturales tricíclicos como inhibidores de la proteína quimioatrayente de monocitos 1. La invención describe un compuesto nuevo de la fórmula (I) y su empleo como un inhibidor de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. También se describe el empleo de los compuestos conocidos en la bibliografía científica como la gunacina y la gunacina saponificada como inhibidores de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. Los compuestos son producidos por la fermentación del hongo Scytalidium flavo-brumeum. Los compuestos son útiles en el tratamiento de ateroesclerosis y otras enfermedades en las cuales se implican la superestimulación de infiltración por monocitos y daño al tejido por macrófagos.</description><edition>7</edition><language>eng ; spa</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011216&DB=EPODOC&CC=ES&NR=2162545A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20011216&DB=EPODOC&CC=ES&NR=2162545A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VALMASEDA JADU MANUEL</creatorcontrib><creatorcontrib>ELSON STEVE W</creatorcontrib><creatorcontrib>DIEZ MONEDERO EMILIO</creatorcontrib><creatorcontrib>SANCHEZ-PUELLES JOSE MARIA</creatorcontrib><creatorcontrib>DE LA FUENTE CARRALERO JESUS</creatorcontrib><creatorcontrib>HUESO RODRIGUEZ JUAN ANTONIO</creatorcontrib><title>Set of monocyte I chemically attractive protein inhibitors used for treating e.g. arteriosclerosis comprises natural tricyclic products of fermentation</title><description>Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors.
Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors. (Machine-translation by Google Translate, not legally binding)
Productos naturales tricíclicos como inhibidores de la proteína quimioatrayente de monocitos 1. La invención describe un compuesto nuevo de la fórmula (I) y su empleo como un inhibidor de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. También se describe el empleo de los compuestos conocidos en la bibliografía científica como la gunacina y la gunacina saponificada como inhibidores de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. Los compuestos son producidos por la fermentación del hongo Scytalidium flavo-brumeum. Los compuestos son útiles en el tratamiento de ateroesclerosis y otras enfermedades en las cuales se implican la superestimulación de infiltración por monocitos y daño al tejido por macrófagos.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjjtuAlEMRaehiIA9eAMg8UuPECipSY-MuQOW3jyPbE-kWUm2G5CygFS3OefovjU_ZyRZS51VkzFBnyQPdCpcykic6Syp36DeLaGVtD70qmkeNARu1JpTOji13gnL-5LYE64WUuAWGiTW9a6BoMo5OJenoDJKUXllb4NkvD608A41nymrs2bScgnM_3ba0On4dfhYoLcLomdBRV6O5_Xqfb3b7varzT-QX_rJUtY</recordid><startdate>20011216</startdate><enddate>20011216</enddate><creator>VALMASEDA JADU MANUEL</creator><creator>ELSON STEVE W</creator><creator>DIEZ MONEDERO EMILIO</creator><creator>SANCHEZ-PUELLES JOSE MARIA</creator><creator>DE LA FUENTE CARRALERO JESUS</creator><creator>HUESO RODRIGUEZ JUAN ANTONIO</creator><scope>EVB</scope></search><sort><creationdate>20011216</creationdate><title>Set of monocyte I chemically attractive protein inhibitors used for treating e.g. arteriosclerosis comprises natural tricyclic products of fermentation</title><author>VALMASEDA JADU MANUEL ; ELSON STEVE W ; DIEZ MONEDERO EMILIO ; SANCHEZ-PUELLES JOSE MARIA ; DE LA FUENTE CARRALERO JESUS ; HUESO RODRIGUEZ JUAN ANTONIO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2162545A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2001</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>VALMASEDA JADU MANUEL</creatorcontrib><creatorcontrib>ELSON STEVE W</creatorcontrib><creatorcontrib>DIEZ MONEDERO EMILIO</creatorcontrib><creatorcontrib>SANCHEZ-PUELLES JOSE MARIA</creatorcontrib><creatorcontrib>DE LA FUENTE CARRALERO JESUS</creatorcontrib><creatorcontrib>HUESO RODRIGUEZ JUAN ANTONIO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VALMASEDA JADU MANUEL</au><au>ELSON STEVE W</au><au>DIEZ MONEDERO EMILIO</au><au>SANCHEZ-PUELLES JOSE MARIA</au><au>DE LA FUENTE CARRALERO JESUS</au><au>HUESO RODRIGUEZ JUAN ANTONIO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Set of monocyte I chemically attractive protein inhibitors used for treating e.g. arteriosclerosis comprises natural tricyclic products of fermentation</title><date>2001-12-16</date><risdate>2001</risdate><abstract>Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors.
Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products (I). Set of monocyte I chemically-attractive inhibitors comprises natural tricyclic products of formula (I). (I) Are prepared by fermentation of Scytalidum flavo-brumeum and inhibit union in the monocyte I protein and the receptors. (Machine-translation by Google Translate, not legally binding)
Productos naturales tricíclicos como inhibidores de la proteína quimioatrayente de monocitos 1. La invención describe un compuesto nuevo de la fórmula (I) y su empleo como un inhibidor de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. También se describe el empleo de los compuestos conocidos en la bibliografía científica como la gunacina y la gunacina saponificada como inhibidores de la unión entre en la proteína quimioatrayente de monocitos 1 y sus receptores. Los compuestos son producidos por la fermentación del hongo Scytalidium flavo-brumeum. Los compuestos son útiles en el tratamiento de ateroesclerosis y otras enfermedades en las cuales se implican la superestimulación de infiltración por monocitos y daño al tejido por macrófagos.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_ES2162545A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | Set of monocyte I chemically attractive protein inhibitors used for treating e.g. arteriosclerosis comprises natural tricyclic products of fermentation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-07T00%3A31%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VALMASEDA%20JADU%20MANUEL&rft.date=2001-12-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2162545A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |